Abstract
I would like to share some thoughts about where we are going in our tamoxifen research program at Wisconsin. We are looking toward the possibility of long-term use of tamoxifen as adjuvant therapy and, as a chemosuppressive agent in healthy women who do not have breast cancer, but are at increased risk for this disease. With these possibilities in mind, we are carefully assessing the biological effects of tamoxifen.